| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Departments of Internal Medicine (F.M., N.C., E.F.) and Neurosciences (G.S., L.Ma., L.Mu.), University of Pisa, Pisa, Italy
Address all correspondence and requests for reprints to: Fabio Monzani, M.D., Department of Internal Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy.
 |
Abstract |
|---|
 Top Abstract IntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
We conclude that muscle energy metabolism is impaired in sHT in rough proportion to the known duration of the disease. Early L-T4 therapy may be useful not only to provide specific treatment for such metabolic changes, but also to avoid progression to frank hypothyroidism.
|
Introduction |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Subclinical hypothyroidism (sHT) is defined solely by the elevation in circulating TSH levels in the face of normal free thyroid hormone levels (5). Several studies, however, suggest that sHT may be associated with significant psychiatric and neurological dysfunction. There is also growing evidence for the presence of metabolic and cardiovascular abnormalities similar to those typical of overt hypothyroidism (6, 7, 8, 9).
The aim of the present study was to evaluate in patients with sHT the possible presence of alterations in muscle energy metabolism similar to those observed in overt hypothyroidism. To this purpose, circulating lactate and pyruvate levels measured in the resting state and during aerobic dynamic exercise were compared to those in healthy control subjects.
|
Subjects and Methods |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
We studied 12 patients (10 women and 2 men; mean age, 44.5 yr; range, 24–63 yr) with sHT, as judged by elevated serum TSH levels (>4.0 mIU/L) and free thyroid hormones (FT4 and FT3) within the normal range. The etiology of sHT was as follows: postsurgery (n = 2), Hashimoto’s disease (n = 8), and radioiodine therapy (n = 2). Nine patients complained of mild neuromuscular symptoms, such as fatigue, cramps, paresthesias, and muscle weakness. In all patients the onset of sHT was well established, as they had been followed for several months before serum TSH elevation was detected because of the known thyroid disease. The control group included 10 sex- and age-matched healthy volunteers (8 women and 2 men; mean age, 43.2 yr; range, 28–60 yr), recruited among staff and relatives of patients attending the Department of Internal Medicine.
Cardiovascular, respiratory, and neuromuscular diseases were excluded in both patients and controls by a complete clinical work-up. Routine laboratory chemistry was normal in all, and none were taking any drugs. Body mass index was 26.4 ± 3.1 kg/m2 (mean ± SD) in the control group and 27.2 ± 2.7 in sHT patients. No study subject was involved in competitive sports. Before inclusion in the protocol, a blood sample for the determination of FT4, FT3, antithyroglobulin antibodies (AbTg), antithyroid peroxidase antibodies (AbTPO), and TSH was obtained at 0800 h after an overnight fast.
Exercise protocol
The exercise was performed at least 4 h after a normal mixed meal with the subjects sitting; the test arm rested on a cushioned table with the elbow extended upward to approximately heart level. At the start of each experiment, the patient performed three brief (<3-s) maximal efforts on a hand-grip dynamometer at 3-min intervals. The highest tension recorded was taken as the maximal voluntary contraction (MVC) (10). After a 15-min rest, the test began with a first bout at 10% of MVC, then continued through successive 10% increments, achieving 50% of MVC (unless exhaustion developed at lower levels of exercise). Exhaustion was defined as the subject being unable to keep up with exercise at the target force. Each bout consisted of 1-min intermittent (one per s) contractions on the hand-grip dynamometer followed by a 2-min rest.
The protocol was chosen on the assumption that exercise under these conditions is mainly aerobic at the beginning and then progressively anaerobic as the contraction level increases (11) due mainly to the recruitment sequence of slow and fast motor units (12).
Blood glucose, lactate, and pyruvate concentrations were measured in the resting state and at each interbout interval by collecting samples from a catheter inserted into an antecubital vein of the exercising arm. The average increment in lactate and pyruvate was calculated as the mean of all interstep increments (interbout value divided by the basal value).
The exercise protocol was approved by the local ethics committee, and all study subjects gave their written informed consent.
Methods
Serum FT4, FT3, and AbTPO levels were measured by specific RIA, AbTg levels were determined by specific immunoradiometric assay, and TSH was measured with the use of an ultrasensitive immunoradiometric method. The normal ranges are as follows: FT4, 7.2–19.3 pmol/L; FT3, 3.7–8.6 pmol/L; TSH, 0.3–4.0 mIU/L; AbTPO, less than 15 IU/L; and AbTg, less than 50 IU/L. Blood glucose was measured on an Automatic Analyzer Hitachi 717 (Boehringer Mannheim, Mannheim, Germany). Whole blood lactate and pyruvate levels were assayed spectrophotometrically on a ERIS Analyzer 6170 (Eppendorf Geratebau, Hamburg, Germany). The normal ranges are as follows: lactate, 0.6–1.7 mmol/L; and pyruvate, 60–170 µmol/L. Blood samples were collected into iced tubes containing 1 mol/L perchloric acid for immediate deproteinization; the supernatant obtained from centrifugation was stored at -20 C and assayed within 30 days.
Statistical analysis
Data are expressed as the mean ± SD. The data analysis was carried out using the Mann-Whitney U test for independent samples, the Wilcoxon test for paired data, ANOVA, and Spearman rank correlation test, as appropriate. Linear regression analysis was carried using standard techniques. Statistical significance was assigned for P < 0.05.
|
Results |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Under basal conditions, blood glucose, lactate, and pyruvate levels
were not significantly different between patients and controls (Table 1
). Only one patient was unable to
complete the exercise protocol, and he stopped at the fourth step (40%
of MVC).
|
) were significantly higher in sHT
patients than in controls from the third exercise step onward
[2.6 ± 0.3 vs. 1.6 ± 0.2 mmol/L
(P = 0.02) at 30%, 3.1 ± 0.3 vs.
1.9 ± 0.2 (P = 0.008) at 40%, and 3.4 ±
0.3 vs. 1.9 ± 0.2 (P = 0.002) at 50%
of the MVC]. Moreover, the mean lactate increment was significantly
higher in patients than in controls (P = 0.02; Table 1
)
and was directly related (r2 = 0.44; P =
0.02) to the duration of sHT (Fig. 2). In
contrast, no correlation was found between mean lactate increments and
serum TSH, FT3, and FT4 levels.
|
|
). As a
consequence, the time course of the lactate/pyruvate ratio was
essentially superimposable on that of lactate in both controls and
patients (Fig. 1C). Thus, the mean lactate/pyruvate ratio increment was
significantly higher in patients than in controls (P =
0.02; Table 1) and correlated (r2 = 0.36; P
< 0.05) with the duration of sHT, but not with serum TSH,
FT3, and FT4 levels. No significant changes in blood glucose levels were observed during exercise in either patients or controls.
|
Discussion |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
We tested the possibility that defective mitochondrial oxidative metabolism may be present in sHT. As excessive lactate production during submaximal exercise is one of the main markers of in vivo functional mitochondrial impairment (17, 18), we studied venous lactate kinetics during incremental exercise in a group of patients with sHT of known origin and duration.
As previously reported in overt hypothyroidism (19), this study shows no differences in blood lactate and pyruvate levels between patients and controls at rest. However, the absolute lactate value as well as the mean lactate increment were significantly higher in sHT patients than in controls during exercise. This result is consistent with the possibility that during step-up exercise, muscle glycolysis exceeds pyruvate oxidation, resulting in rates of lactate production and release in excess of simultaneous lactate uptake; lactate, therefore, accumulates in the venous effluent. The higher lactate/pyruvate ratio of the sHT patients and the normal pyruvate absolute concentrations suggest that more severe intracellular acidosis may be responsible for pushing the excess pyruvate through the lactic dehydrogenase reaction.
Abnormal accumulation of lactate has been reported in hypothyroid dog muscles during exercise (20), but similar results in patients with overt hypothyroidism have not, to our knowledge, been reported. Nuclear magnetic resonance studies in working hypothyroid human and rat muscles (3, 4) have documented a decreased intracellular pH during muscle exercise. As intracellular pH changes are related to lactate production (21), these results have been interpreted to reflect reduced mitochondrial oxidative capacity.
The presence of T3 receptors on the mitochondrial membrane of skeletal muscle (22) suggests a direct impact of thyroid hormones on oxidative metabolism and may provide a biochemical basis for the muscle dysfunction observed in frank hypothyroidism. In our study, however, there was no correlation between mean lactate and lactate/pyruvate ratio increments during exercise and serum TSH or thyroid hormone levels. Furthermore, the definition of sHT implies that circulating thyroid hormone levels are still in the normal range. Therefore, it may seem puzzling to find metabolic abnormalities similar to those typical of frank hypothyroidism. However, our study shows that the duration of sHT may play an important role in the development of defective muscle energy metabolism. Thus, exposure (i.e. time x concentration product) of skeletal muscle to thyroid hormones may be an important parameter in the coupling of glycolysis and oxidation. Minute decrements in hormone synthesis may over time lead to both biochemical signs and clinical symptoms qualitatively similar to those of overt hypothyroidism. If this hypothesis is correct, it should be possible to show that early L-T4 treatment of sHT patients corrects muscle energy metabolism at the same time as it improves symptoms. With regard to this, multiple metabolic defects, including dyslipoproteinemia (8, 9), altered cardiac performance (6, 23), and neurobehavioral changes (7), had been previously reported in sHT, and L-T4 treatment appeared effective in correcting at least some of these conditions.
In conclusion, our data show that patients with sHT and muscle symptoms present evidence of mitochondrial oxidative dysfunction, possibly heralding the severe abnormalities of muscle metabolism of frank hypothyroidism. Early L-T4 therapy may be useful not only to provide specific treatment for such metabolic changes, but also to avoid progression to frank hypothyroidism.
|
Acknowledgments |
|---|
Received April 10, 1997.
Revised July 8, 1997.
Accepted July 10, 1997.
|
References |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
This article has been cited by other articles:
 |
|
 |
|
  B. Biondi and D. S. Cooper The Clinical Significance of Subclinical Thyroid Dysfunction Endocr. Rev., February 1, 2008; 29(1): 76 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Y. Z. Forrest, J. M. Zmuda, and J. A. Cauley Correlates of Decline in Lower Extremity Performance in Older Women: A 10-Year Follow-Up Study J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2006; 61(11): 1194 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Caraccio, A. Natali, A. Sironi, S. Baldi, S. Frascerra, A. Dardano, F. Monzani, and E. Ferrannini Muscle Metabolism and Exercise Tolerance in Subclinical Hypothyroidism: A Controlled Trial of Levothyroxine J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4057 - 4062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gullu, H. Sav, and N. Kamel Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism Eur. J. Endocrinol., March 1, 2005; 152(3): 355 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. McDermott and E. C. Ridgway Subclinical Hypothyroidism Is Mild Thyroid Failure and Should be Treated J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4585 - 4590. [Full Text] [PDF]
|
|
|
|
|
|
F. Monzani, V. Di Bello, N. Caraccio, A. Bertini, D. Giorgi, C. Giusti, and E. Ferrannini Effect of Levothyroxine on Cardiac Function and Structure in Subclinical Hypothyroidism: A Double Blind, Placebo-Controlled Study J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1110 - 1115. [Abstract] [Full Text]
|
|
|
|
|
|
Diagnosis of Hidden Central Hypothyroidism in Survivors of Childhood Cancer J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4472 - 4479. [Abstract] [Full Text]
|
|
|
|
|
|
I. W. Beyer, R. Karmali, N. Demeester-Mirkine, E. Cogan, and M. J. Fuss Muscle Dysfunction in Subclinical Hypothyroidismd J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1822b - 1823. [Full Text]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
